FungiScope - A Global Emerging Fungal Infection Registry (FungiScope)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01731353|
Recruitment Status : Recruiting
First Posted : November 21, 2012
Last Update Posted : November 4, 2022
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease|
|Invasive Fungal Disease|
The specific objectives are:
- To determine the fungal species causing invasive fungal infection in different parts of the world.
- To determine the clinical pattern of disease and document procedures performed for confirmation of the diagnosis.
- To describe the therapeutic regimens used and their efficacy.
- To share clinical isolates among the contributors of Fungiscope.
- To develop molecular biology tools for identification of strains in histopathologically proven invasive fungal infection.
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||FungiScope - A Global Emerging Fungal Infection Registry|
|Study Start Date :||March 2003|
|Estimated Primary Completion Date :||December 2025|
|Estimated Study Completion Date :||December 2025|
Emerging fungal infections
Web-based registry of invasive infections by emerging fungi
- Treatment efficacy of emerging fungal infections [ Time Frame: At 90 days from diagnosis ]failure, stable disease, partial response or complete response
Biospecimen Retention: Samples Without DNA
- fixed tissue
- fungal culture
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||Child, Adult, Older Adult|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- Cultural, histopathological, antigen or DNA evidence of invasive fungal infection
- Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci
- Endemic fungal infection such as coccidioidomycosis or histoplasmosis
- Colonisation or other non-invasive infection
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01731353
|Contact: Oliver A Cornely, Prof.||+49 221 478 ext email@example.com|
|University Hospital Cologne||Recruiting|
|Cologne, NRW, Germany, 50937|
|Contact: Oliver A Cornely, Prof. +49 221 478 ext 6494 firstname.lastname@example.org|
|Contact: Danila Seidel, PhD +49 221 478 ext 97343 email@example.com|
|Sub-Investigator: Philipp Köhler, MD|
|Principal Investigator:||Oliver A. Cornely, Professor||University Hospital of Cologne|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
|Responsible Party:||Oliver Cornely, MD, Dr. med., University of Cologne|
|Other Study ID Numbers:||
|First Posted:||November 21, 2012 Key Record Dates|
|Last Update Posted:||November 4, 2022|
|Last Verified:||November 2022|
invasive fungal infection
Invasive Fungal Infections
Bacterial Infections and Mycoses